Fundraising Fox
/Companies
Sign in

Vitract

Techstars '22

Mississauga, CA · 10 employees on LinkedIn · 2 known investors

Find your way into Vitract

Sign up to find every way you can get introduced to Vitract

  • Your email: who you already know at Vitract, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Vitract team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Vitract develops an advanced gut testing platform using whole-genome sequencing and AI analytics to assess microbiome health and provide personalized insights. The company serves individuals seeking diagnostic and preventive gut health solutions grounded in microbiome science.

Also known as Vitract Inc.

AI & Machine LearningDigital HealthHealthtechWellness & Fitness

Investors · 2

Techstarslisted by TechstarsBoulder · $220K

How we know: the Techstars portfolio · funding news · open dataset · Top 3000 Accelerator Startups (no YC) 2026-08 · Not right? Tell us

Company profile

researched Sep 2026

Vitract is a gut microbiome testing company that sells at-home stool testing kits and returns reports on microbiome composition and related health markers. It offers three products: GutScan, based on 16S sequencing; DeepGut, based on deep shotgun sequencing; and DeepGut PLUS, which combines deep shotgun sequencing with directly measured digestive and inflammatory biomarkers such as elastase, calprotectin, sIgA and lactoferrin. The company describes itself as the sole provider of both 16S and shotgun microbiome tests.

Reports cover a summary of results, stool biomarkers, microbial life forms, antimicrobial resistance genes, insights into gut-derived metabolites, and food and supplement recommendations. GutScan identifies bacteria and archaea and reports 29 metabolites, while the DeepGut tiers resolve organisms to strain level across bacteria, archaea, fungi, viruses, protozoa and worms and report more than 40 metabolites. The company states that recommendations are linked directly to supporting scientific evidence, and that follow-up testing is used to track changes in microbiome indicators over time. A third-party profile describes Vitract as a gut microbiome testing and research company building advanced and affordable testing to assess gut dysbiosis.

Founding story

Co-founder and CEO Linta Mustafa describes the company as personal, citing her own health struggles and her family's health challenges as motivation for translating gut health science into everyday practical solutions.

Business model

Direct-to-consumer health testing: customers order a kit, which is shipped with free shipping and sample return, provide a stool sample, and receive a digital report with personalized food and supplement recommendations and progress tracking. The company also works with practitioners and clinics, and markets repeat follow-up testing to monitor microbiome change.

Sale of microbiome testing kits across three tiers (GutScan, DeepGut, DeepGut PLUS), with follow-up testing for progress tracking.

Traction

The website states the company is trusted by more than 1,000 practitioners as well as clinics and organizations.

Latest developments

Vitract markets a three-tier product line — GutScan (16S), DeepGut (deep shotgun) and DeepGut PLUS (deep shotgun plus digestive and inflammatory biomarkers) — with sample reports, food and supplement recommendations and progress tracking.

▸Full profile — market position, technology, go-to-market, geography, history

Market position

Positions itself against legacy practitioner tests and other consumer tests on sequencing depth, breadth of organisms detected, number of metabolites reported and turnaround time, claiming to be the only provider offering both 16S and shotgun microbiome tests. Peers listed by an investor directory include Jona Health, Flore, Alba Health, Parallel Health and DayTwo.

Offering both 16S and shotgun sequencing options; strain-level resolution and detection of fungi, viruses, protozoa and worms in the DeepGut tiers; reporting of more than 40 gut-derived metabolites; antimicrobial resistance gene reporting; direct digestive and inflammatory biomarker measurement in DeepGut PLUS; and linking each recommendation to the underlying evidence.

Technology

16S rRNA sequencing (GutScan) and deep shotgun metagenomic sequencing (DeepGut, DeepGut PLUS), which the company contrasts with PCR or shallow shotgun approaches used by other consumer and practitioner tests. DeepGut PLUS adds direct measurement of digestive and inflammatory biomarkers including elastase, calprotectin, sIgA and lactoferrin. Outputs include strain-level taxonomy across bacteria, archaea, fungi, viruses, protozoa and worms, antimicrobial resistance genes, and metabolite insights.

Go-to-market

Online direct sales of kits through the company website, combined with a practitioner and clinic channel, and content marketing via a blog covering gut health topics such as at-home testing, pregnancy, mental health, probiotics and obesity.

Individuals with digestive symptoms such as bloating or chronic health conditions, people seeking diet and supplement personalization, and performance- and biohacking-oriented consumers (athletes, executives). The company also states it is used by practitioners, clinics and organizations.

Geography

Ontario, Canada-based, with locations listed including Mississauga, Scarborough, Old Toronto and North York in Toronto, plus Dover, Delaware and the United States.

History

The company was founded in 2022 and appears on the Techstars job board, where it is listed at pre-seed stage; an investor directory later lists it at seed stage. Its early positioning described a digital health practice addressing mental illness at its root cause by pairing gut microbiome technology with personalized nutrition, while its current site focuses on consumer and practitioner microbiome testing products (GutScan, DeepGut, DeepGut PLUS).

Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.

Key figures

latest reported
EmployeesJan 20251-10 (Techstars profile); 11-20 (Prospeo profile)
HeadcountAug 202610
Metabolites reportedJan 202529 metabolites (GutScan); more than 40 metabolites (DeepGut and DeepGut PLUS)
Practitioners using VitractJan 20251,000 practitioners
Results turnaroundJan 2025Results available within 10 days; product comparison table lists 2-3 weeks (DeepGut PLUS) and 3 weeks (GutScan, DeepGut)
Test kit delivery timeJan 2025Testing kits arrive within 3-5 days

Company-reported or press-reported figures, each dated to when it was claimed — not independently audited.

Related companies · 8

Next|HealthNext Health operates wellness clinics offering IV vitamin therapy, NAD+ drips, peptide therapy, and bioidentical hormone optimization delivered through in-lounge sessions and membership plans. It serves consumers focused on longevity and health optimization, with locations in cities including West Hollywood, Century City, Studio City, New York City, Nashville, and Maui.
Tiny HealthTiny Health offers at-home gut and vaginal microbiome test kits with age-specific, evidence-based reports that recommend diet, supplement, and lifestyle changes. It targets families across life stages—from preconception and pregnancy through infancy, childhood, and adulthood—to detect microbiome imbalances and support prevention of conditions like eczema, allergies, and GI issues.
Viome Life SciencesViome offers at-home tests that analyze the gut and oral microbiome plus cellular blood samples using mRNA/metatranscriptomic sequencing, returning 70+ health scores (including biological age and inflammation) and personalized food and supplement recommendations. The direct-to-consumer service, analyzed in a CLIA-certified lab, is aimed at individuals seeking insights into digestion, metabolism, and overall wellness.
JonaJona provides an AI-powered gut microbiome analysis that interprets scientific literature to generate personalized health insights and recommendations for consumers. The service covers areas including GI, skin, metabolic, and brain health as well as physical performance, and is FSA/HSA eligible.
BIOHMBIOHM sells probiotic supplements and at-home gut test kits that analyze the microbiome, with results reviewed by a microbiome-trained registered nutritionist who provides personalized diet and supplement recommendations. Its formula combines bacteria, fungi, and a digestive enzyme intended to support digestive health.
AnimalbiomeAnimalBiome develops microbiome testing and probiotic products for dogs and cats to improve digestive health and overall wellness. The company serves pet owners and veterinarians through science-based solutions focused on understanding and optimizing the pet gut microbiome.
Rupa HealthA platform that enables healthcare providers to order, track, and receive lab test results from multiple laboratory companies through a single dashboard, supporting both in-person and telehealth patients with flexible billing options and EHR integration.
ZOEZOE provides personalized nutrition advice and testing based on scientific research to help individuals improve their health and dietary habits. The company operates the world's largest nutrition study and offers a mobile app with meal tracking and health insights.

Companies working in the same space as Vitract.

Timeline · 1

launches, deals, and filings
Jan 2025
GutScan, DeepGut and DeepGut PLUS microbiome test kits offered

Vitract markets three microbiome testing tiers: GutScan (16S sequencing, 29 metabolites), DeepGut (deep shotgun sequencing, strain-level, >40 metabolites) and DeepGut PLUS (deep shotgun plus direct digestive and inflammatory biomarker measurement).

source ↗

Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.

▸Research sources · 8

primary sources listed

8 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does Vitract do?
Vitract sells 16S and shotgun-sequencing gut microbiome tests with personalized food and supplement recommendations.
Who are Vitract's investors?
Vitract's investors include Roosh Ventures, Techstars.
Where is Vitract headquartered?
Vitract is headquartered in Mississauga, CA.